Category: Vaccines
Global Vaccines
-
Serum-free Media Market Size, Trends, Analysis, and Outlook By Product (Classical Media, Specialty Media, Stem Cell Media, Others), By End-user (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, Others), By Application (Bioproduction, Vaccine Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Others), By Animal Origin, Animal-derived Serum-Free Media, Plant-derived Serum-Free Media, Synthetic Serum-Free Media), By Distribution Channel (Direct Sales, Distributor), by Region, Country, Segment, and Companies, 2024-2030
... Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Others), By Animal Origin, Animal-derived Serum-Free Media, Plant-derived Serum-Free Media, Synthetic Serum-Free Media), By Distribution Channel (Direct Sales, Distributor), by Region, Country, Segment, and Companies, 2024-2030 ... Read More
-
Global Vaccines & Vaccination Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Vaccines & Vaccination is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Ruminant Vaccines Market Size, Trends, Analysis, and Outlook By Animal (Cattle, Sheep & Goats), By Vaccine (Modified/ Attenuated Live, Inactivated, Others), By Indication (BVD Infection, Bovine Respiratory Diseases, Leptospirosis, Clostridial diseases, Diarrhea/ Scours, FMD, Others), By Route of Administration (Injectable, Intranasal), by Region, Country, Segment, and Companies, 2024-2030
... By Route of Administration (Injectable, Intranasal), by Region, Country, Segment, and Companies, 2024-2030 The global Ruminant Vaccines market size is poised to register 6.8% growth from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Viral Vector Contract Development Manufacturing Organizations Market Size, Trends, Analysis, and Outlook By Vector (Adenovirus, Retrovirus, Adeno-Associated Virus, Lentivirus, Others), By Workflow (Upstream Manufacturing, Downstream Manufacturing), By Application (Antisense & RNAi Therapy, Gene Therapy-, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical & Biopharmaceutical Companies, Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical & Biopharmaceutical Companies, Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global Viral Vector Contract Development Manufacturing Organizations market size is poised to register 14.5% growth ... Read More
-
Primary Cell Culture Market Size, Trends, Analysis, and Outlook By Product (Primary Cells, Reagents and Supplements, Media), By Separation Method (Explant Method, Enzymatic Degradation, Mechanical Separation, Others), By Type (Animal Cells, Human Cells), By Application (Cell & Gene Therapy Development, Vaccine Production, Model System, Virology, Prenatal Diagnosis, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Cell & Gene Therapy Development, Vaccine Production, Model System, Virology, Prenatal Diagnosis, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Primary Cell Culture market size is poised to register 12.97% growth from 2024 ... Read More
-
Influenza Medications Market Size, Trends, Analysis, and Outlook By Type (Antiviral Drugs, Antihistamines, Vaccines, Others), By Distribution Channel ( Hospital Pharmacy, Independent Pharmacy and Drug Store, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... The global Influenza Medications market size is poised to register 5.2% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Influenza Medications market ... Read More
-
Neglected Tropical Disease Treatment Market Size, Trends, Analysis, and Outlook By Disease (Dengue, Rabies, Trachoma, Buruli ulcer, Yaws, Leprosy, Chagas disease, Human African trypanosomiasis, Leishmaniases, Soil-transmitted helminthiases, Others), By Product (Drugs, Vaccines), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Neglected Tropical Disease Treatment market size is poised to register 4.94% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Fetal Bovine Serum Market Size, Trends, Analysis, and Outlook By Product (Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Others), By Application (Biopharmaceuticals, Cell Culture Media, Human and Animal Vaccine Production, Others), By End-User (Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, Others), by Region, Country, Segment, and Companies, 2024-2030
... By End-User (Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Fetal Bovine Serum market size is poised to register 7.41% growth from 2024 to 2030, ... Read More
-
Animal Vaccines Market Size, Trends, Analysis, and Outlook By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Animal Type (Livestock, Poultry, Aqua, Ruminants, Swine, Companion, Canine, Feline, Others), By Route of Administration (Subcutaneous, Intramuscular, Intranasal), by Region, Country, Segment, and Companies, 2024-2030
... of Administration (Subcutaneous, Intramuscular, Intranasal), by Region, Country, Segment, and Companies, 2024-2030 The global Animal Vaccines market size is poised to register 6.59% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Adeno Associated Virus Vector Manufacturing Market Size, Trends, Analysis, and Outlook By Scale of Operations (Clinical, Preclinical, Commercial), By Therapeutic Area (Hematological Diseases, Infectious Diseases, Genetic Disorders, Neurological Disorders, Ophthalmic Disorders, Others), By Application (Cell Therapy, Gene Therapy, Vaccine), By Method (In Vitro, In Vivo), by Region, Country, Segment, and Companies, 2024-2030
... Therapy, Gene Therapy, Vaccine), By Method (In Vitro, In Vivo), by Region, Country, Segment, and Companies, 2024-2030 The global Adeno Associated Virus Vector Manufacturing market size is poised to register 23.77% growth from 2024 to ... Read More
-
AAV Contract Development and Manufacturing Organizations Market Size, Trends, Analysis, and Outlook By Workflow (Upstream Processing, Downstream Processing), By Type (Adherent Culture, Suspension Culture), By Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical and Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global AAV Contract Development and Manufacturing Organizations market size is poised to register ... Read More
-
Vaccine Delivery Devices Market Size, Trends, Analysis, and Outlook By Device (Syringes, Jet Injectors, Others), By Route of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Others), by Region, Country, Segment, and Companies, 2024-2030
... Vaccine Delivery Devices market size is poised to register 7.35% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Vaccine Delivery Devices market ... Read More
-
Smart Syringes Market Size, Trends, Analysis, and Outlook By Therapeutics (Auto-disable syringes, Active safety syringes, Passive safety syringes), By Application (Drug delivery, Vaccination, Blood specimen collection), By End-user (Hospitals and HMOs, Diabetic patients, Family practices, Psychiatrists, Others), by Region, Country, Segment, and Companies, 2024-2030
... Psychiatrists, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Smart Syringes market size is poised to register 10.4% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. ... Read More
-
Human Rabies Vaccines Market Size, Trends, Analysis, and Outlook By Cell Line Type (Chick Embryo Cells, Vero Cell, BHK Cells, Others), By Application (Pre Exposure Prophylaxis, Post Prophylaxis), By Route of Administration (Intravenous, Subcutaneous), By End-User (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... End-User (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Human Rabies Vaccines market size is poised to register 5.02% growth ... Read More
-
The 2025-2030 World Outlook for Human Papillomavirus Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Human Influenza Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Hepatitis B Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Clostridium Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Cholera Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Zika Virus Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Subunit Animal Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Potential Analysis of Human DNA Vaccines
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Human Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Live Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Paediatric Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
Research Assistance
